Skip to main navigation Skip to search Skip to main content

The tumor-activated IL-12 prodrug WTX-330 expanded/activated tumor infiltrating lymphocytes and caused tumor regression in patients with refractory solid tumors: interim data from an ongoing Ph1 study

  • D Mahalingam
  • , Brendan Curti
  • , See full list of authors in comments

Research output: Other contribution

Original languageUndefined/Unknown
StatePublished - Nov 1 2024

Publication series

NameArticles, Abstracts, and Reports

Cite this